Table 3.
Cycle 1 (n = 14)*,** | Nimesulide 100 mg | Acetaminophen 1 g | Meriva 1.5 g | |||
---|---|---|---|---|---|---|
Poor | 2 | 0 | 0 | |||
Fair | 4 | 0 | 0 | |||
Good | 0 | 0 | 1 | |||
Excellent | 8 | 14 | 13 | |||
Cycle 2 (n = 15)*** | Nimesulide 100 mg | Acetaminophen 1 g | Meriva 2.0 g | |||
| ||||||
Poor | 6 | 0 | 0 | |||
Fair | 3 | 0 | 8 | |||
Good | 1 | 0 | 1 | |||
Excellent | 5 | 15 | 6 |
Notes: After each medication intake, subjects completed a questionnaire with the following tolerability scores: poor, fair, good, excellent. Data are presented as the number of subjects with each score. The number of subjects for each treatment cycle is reported in brackets. *P < 0.0084, correspondence analysis; **P < 0.0150 Pearson Chi-square test; ***P < 0.0001, correspondence analysis and Pearson Chi-square test.